122
Views
0
CrossRef citations to date
0
Altmetric
Review

Balloon aortic valvuloplasty: current status and future prospects

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon & show all
Pages 389-402 | Received 25 Feb 2022, Accepted 04 May 2022, Published online: 15 May 2022

References

  • Osnabrugge RL, Mylotte D, Head SJ, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013;62(11):1002–1012.
  • Bordoni B, Saia F, Ciuca C, et al. Prevalence of degenerative aortic valve stenosis in the elderly: results of a large community-based epidemiological study. G Ital Cardiol (Rome). 2013;14(4):262–268.
  • Kapadia SR, Leon MB, Makkar RR, et al. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385(9986):2485–2491.
  • Iung B, Delgado V, Rosenhek R, et al., Contemporary presentation and management of valvular heart disease: the eurobservational research programme valvular heart disease II survey. Circulation. 2019;140(14):1156–1169.
  • Frey N, Steeds RP, Rudolph TK, et al. Symptoms, disease severity and treatment of adults with a new diagnosis of severe aortic stenosis. Heart. 2019;105(22):1709–1716.
  • Otto CM, Mickel MC, Kennedy JW, et al. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation. 1994;89(2):642–650.
  • Saia F, Marrozzini C, Ciuca C, et al. Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. EuroIntervention. 2013;8(12):1388–1397.
  • Ben-Dor I, Pichard AD, Satler LF, et al. Complications and outcome of balloon aortic valvuloplasty in high-risk or inoperable patients. JACC Cardiovasc Interv. 2010;3(11):1150–1156.
  • Dawson L, Huang A, Selkrig L, et al. Utility of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. Open Heart. 2020;7(1):e001208.
  • Vahanian A, Beyersdorf F, Praz F, et al. ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561–632.
  • Otto CM, Nishimura RA, Bonow RO, et al. ACC/aha guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143(5):e72–e227.
  • Barbato E, Noc M, Baumbach A, et al. Mapping interventional cardiology in Europe: the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Atlas Project. Eur Heart J. 2020;41(27):2579–2588.
  • Durko AP, Osnabrugge RL, Van Mieghem NM, et al. Annual number of candidates for transcatheter aortic valve implantation per country: current estimates and future projections. Eur Heart J. 2018;39(28):2635–2642.
  • Kawsara A, Alqahtani F, Eleid MF, et al. Balloon aortic valvuloplasty as a bridge to aortic valve replacement: a contemporary nationwide perspective. JACC Cardiovasc Interv. 2020;13(5):583–591.
  • Eugene M, Urena M, Abtan J, et al. Effectiveness of rescue percutaneous balloon aortic valvuloplasty in patients with severe aortic stenosis and acute heart failure. Am J Cardiol. 2018;121(6):746–750.
  • Araque JC, Greason KL, Suri RM, et al. The role of balloon aortic valvuloplasty in patients with aortic valve stenosis and society of thoracic surgeons risk of 15% or higher. Ann Thorac Surg. 2016;101(2):592–597. discussion 597-598.
  • Buchwald AB, Meyer T, Scholz K, et al. Efficacy of balloon valvuloplasty in patients with critical aortic stenosis and cardiogenic shock–the role of shock duration. Clin Cardiol. 2001;24(3):214–218.
  • Debry N, Kone P, Vincent F, et al. Urgent balloon aortic valvuloplasty in patients with cardiogenic shock related to severe aortic stenosis: time matters. EuroIntervention. 2018;14(5):e519–e525.
  • Maluenda G, Ben-Dor I, Laynez-Carnicero A, et al. Changes in mitral regurgitation after balloon aortic valvuloplasty. Am J Cardiol. 2011;108(12):1777–1782.
  • Masaki R, Iwasaki M, Tanaka H, et al. Mid-term effect of balloon aortic valvuloplasty on mitral regurgitation in aortic stenosis. Cardiovasc Ultrasound. 2020;18(1):10.
  • Arsalan M, Khan S, Golman J, et al. Balloon aortic valvuloplasty to improve candidacy of patients evaluated for transcatheter aortic valve replacement. J Interv Cardiol. 2018;31(1):68–73.
  • Saia F, Marrozzini C, Moretti C, et al. The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation. EuroIntervention. 2011;7(6):723–729.
  • Szerlip M, Arsalan M, Mack MC, et al. Usefulness of Balloon aortic valvuloplasty in the management of patients with aortic stenosis. Am J Cardiol. 2017;120(8):1366–1372.
  • Eltchaninoff H, Durand E, Borz B, et al. Balloon aortic valvuloplasty in the era of transcatheter aortic valve replacement: acute and long-term outcomes. Am Heart J. 2014;167(2):235–240.
  • Attisano T, Silverio A, Bellino M, et al. Balloon aortic valvuloplasty for urgent treatment of severe aortic stenosis during coronavirus disease 2019 pandemic: a case report. ESC Heart Fail, (2020).
  • Dvir D, Simonato M, Amat-Santos I, et al. Severe valvular heart disease and COVID-19: results from the multicenter international valve disease registry. Str Heart. 2021;5(4) 424–426.
  • Kolte D, Khera S, Vemulapalli S, et al. Outcomes following urgent/emergent transcatheter aortic valve replacement: insights from the STS/ACC TVT REgistry. JACC Cardiovasc Interv. 2018;11(12):1175–1185.
  • Bianco V, Habertheuer A, Kilic A, et al. Urgent transcatheter aortic valve replacement may be performed with acceptable long-term outcomes. J Card Surg. 2021;36(1):206–215.
  • Ali N, Patel P, Wahab A, et al. A cohort study examining urgent and emergency treatment for decompensated severe aortic stenosis. J Cardiovasc Med (Hagerstown). 2021;22(2):126–132.
  • Chakraborty S, Patel N, Bandyopadhyay D, et al. Readmission following urgent transcatheter aortic valve implantation versus urgent balloon aortic valvuloplasty in patients with decompensated heart failure or cardiogenic shock. Catheter Cardiovasc Interv. 2021;98(3):607–612.
  • Biere L, Durfort A, Fouquet O, et al. Baseline characteristics and outcomes after transcatheter aortic-valve implantation in patients with or without previous balloon aortic valvuloplasty: insights from the France 2 registry. Arch Cardiovasc Dis. 2017;110(10):534–542.
  • Kleczynski P, Kulbat A, Brzychczy P, et al. Balloon aortic valvuloplasty for severe aortic stenosis as rescue or bridge therapy. J Clin Med. 2021;10(20):4657.
  • Kristensen SD, Knuuti J, Saraste A, et al. ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management: the joint task force on non-cardiac surgery: cardiovascular assessment and management of the European society of cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J. 2014;35(35):2383–2431.
  • Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American college of cardiology/American heart association task force on practice guidelines (writing committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery) developed in collaboration with the American society of echocardiography, American society of nuclear cardiology, heart rhythm society, society of cardiovascular anesthesiologists, society for cardiovascular angiography and interventions, society for vascular medicine and biology, and society for vascular surgery. J Am Coll Cardiol. 2007;50(17):1707–1732.
  • Kalarickal P, Liu Q, Rathor R, et al. Balloon aortic valvuloplasty as a bridge to liver transplantation in patients with severe aortic stenosis: a case series. Transplant Proc. 2014;46(10):3492–3495.
  • Calicchio F, Guarracino F, Giannini C, et al. Balloon aortic valvuloplasty before noncardiac surgery in severe aortic stenosis: a single-center experience. J Cardiovasc Med (Hagerstown). 2017;18(2):109–113.
  • Ferre F, Viarnes M, Martin C, et al. Is preoperative balloon aortic valvuloplasty of interest for severe aortic stenosis in Hip fracture surgery? Injury. 2021;52(6):1438–1444.
  • Debry N, Altes A, Vincent F, et al. Balloon aortic valvuloplasty for severe aortic stenosis before urgent non-cardiac surgery. EuroIntervention. 2021;17(8):e680–e687.
  • Yamamoto M, Kagase A, Shimura T, et al. Percutaneous aortic valve intervention in patients scheduled for noncardiac surgery: a Japanese multicenter study. Cardiovasc Revasc Med. 2020;21(5):621–628.
  • Tashiro T, Pislaru SV, Blustin JM, et al. Perioperative risk of major non-cardiac surgery in patients with severe aortic stenosis: a reappraisal in contemporary practice. Eur Heart J. 2014;35(35):2372–2381.
  • Saia F, Moretti C, Dall’Ara G, et al. Balloon aortic valvuloplasty as a bridge-to-decision in high risk patients with aortic stenosis: a new paradigm for the heart team decision making. J Geriatr Cardiol. 2016;13(6):475–482.
  • Otto CM, Kumbhani DJ, Alexander KP, et al. ACC expert consensus decision pathway for transcatheter aortic valve replacement in the management of adults with aortic stenosis: a report of the American college of cardiology task force on clinical expert consensus documents. J Am Coll Cardiol. 2017;69(10):1313–1346.
  • Lantelme P, Lacour T, Bisson A, et al. Futility risk model for predicting outcome after transcatheter aortic valve implantation. Am J Cardiol. 2020;130:100–107.
  • Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J. 2005;26(24):2714–2720.
  • Ramlawi B, Ramchandani M, Reardon MJ. Surgical approaches to aortic valve replacement and repair-insights and challenges. Interv Cardiol. 2014;9(1):32–36.
  • Moretti C, Chandran S, Vervueren PL, et al. Outcomes of patients undergoing balloon aortic valvuloplasty in the TAVI era: a multicenter registry. J Invasive Cardiol. 2015;27(12):547–553.
  • Kamperidis V, Hadjimiltiades S, Ziakas A, et al. Balloon valvuloplasty as destination therapy in elderly with severe aortic stenosis: a cardiac catheterization study. J Geriatr Cardiol. 2015;12(3):218–225.
  • Mantovani F, Clavel MA, Potenza A, et al. Balloon aortic valvuloplasty as a palliative treatment in patients with severe aortic stenosis and limited life expectancy: a single center experience. Aging (Albany NY). 2020;12(16):16597–16608.
  • Khawaja MZ, Sohal M, Valli H, et al. Standalone balloon aortic valvuloplasty: indications and outcomes from the UK in the transcatheter valve era. Catheter Cardiovasc Interv. 2013;81(2):366–373.
  • Hamana T, Iwasaki M, Shinke T, et al. prognostic impact of the clinical frailty scale after balloon aortic valvuloplasty. Circ Rep. 2020;2(6):322–329.
  • Tumscitz C, Di Cesare A, Balducelli M, et al. Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplasty. Heart. 2021;107(11):874–880.
  • Jones DR, Chew DP, Horsfall MJ, et al. Effect of balloon aortic valvuloplasty on mortality in patients with severe aortic stenosis prior to conservative treatment and surgical or transcatheter aortic valve replacement. Heart Lung Circ. 2020;29(5):719–728.
  • Kapadia S, Stewart WJ, Anderson WN, et al. Outcomes of inoperable symptomatic aortic stenosis patients not undergoing aortic valve replacement: insight into the impact of balloon aortic valvuloplasty from the PARTNER trial (placement of aortic transcatheter valve trial). JACC Cardiovasc Interv. 2015;8(2):324–333.
  • Agarwal A, Kini AS, Attanti S, et al. Results of repeat balloon valvuloplasty for treatment of aortic stenosis in patients aged 59 to 104 years. Am J Cardiol. 2005;95(1):43–47.
  • Bordoni B, Moretti C, Marrozzini C, et al. Repeated aortic balloon valvuloplasty in elderly patients with aortic stenosis who are not candidates for definitive treatment. J Invasive Cardiol. 2015;27(12):E277–284.
  • Deharo P, Jaussaud N, Grisoli D, et al. Impact of direct transcatheter aortic valve replacement without balloon aortic valvuloplasty on procedural and clinical outcomes: insights from the France TAVI registry. JACC Cardiovasc Interv. 2018;11(19):1956–1965.
  • Martin GP, Sperrin M, Bagur R, et al. Pre-implantation balloon aortic valvuloplasty and clinical outcomes following transcatheter aortic valve implantation: a propensity score analysis of the UK registry. J Am Heart Assoc. 2017;6(2).
  • Pagnesi M, Kim WK, Conradi L, et al. Impact of predilatation prior to transcatheter aortic valve implantation with the self-expanding acurate neo device (from the multicenter neopro registry). Am J Cardiol. 2020;125(9):1369–1377.
  • Giordano A, Corcione N, Ferraro P, et al. Impact of predilation before transcatheter aortic valve implantation with new-generation devices. Cardiovasc Revasc Med. 2019;20(12):1096–1099.
  • Abramowitz Y, Jilaihawi H, Chakravarty T, et al. Feasibility and safety of balloon-expandable transcatheter aortic valve implantation with moderate or without predilatation. EuroIntervention. 2016;11(10):1132–1139.
  • Ashauer JO, Bonaros N, Kofler M, et al. Balloon-expandable transcatheter aortic valve implantation with or without pre-dilation - results of a meta-analysis of 3 multicenter registries. BMC Cardiovasc Disord. 2019;19(1):172.
  • Bagur R, Kwok CS, Nombela-Franco L, et al. Transcatheter aortic valve implantation with or without preimplantation balloon aortic valvuloplasty: a systematic review and meta-analysis. J Am Heart Assoc. 2016;5(6).
  • Bijuklic K, Haselbach T, Witt J, et al. Increased risk of cerebral embolization after implantation of a balloon-expandable aortic valve without prior balloon valvuloplasty. JACC Cardiovasc Interv. 2015;8(12):1608–1613.
  • Dumonteil N, Terkelsen C, Frerker C, et al. Outcomes of transcatheter aortic valve replacement without predilation of the aortic valve: insights from 1544 patients included in the SOURCE 3 registry. Int J Cardiol. 2019;296:32–37.
  • Toutouzas K, Benetos G, Voudris V, et al., Pre-dilatation versus no pre-dilatation for implantation of a self-expanding valve in all comers undergoing tavr: the direct trial. JACC Cardiovasc Interv. 2019;12(8):767–777.
  • Leclercq F, Robert P, Akodad M, et al., Prior balloon valvuloplasty versus direct transcatheter aortic valve replacement: results from the directavi trial. JACC Cardiovasc Interv. 2020;13(5):594–602.
  • Butter C, Okamoto M, Schymik G, et al. Degree of valve calcification in patients undergoing transfemoral transcatheter aortic valve implantation with and without balloon aortic valvuloplasty: Findings from the multicenter EASE-IT TF registry. Catheter Cardiovasc Interv. 2019;94(3):469–478.
  • Chan PH, Mario CD, Moat N. Transcatheter aortic valve implantation without balloon predilatation: not always feasible. Catheter Cardiovasc Interv. 2013;82(2):328–332.
  • Islas F, Almeria C, Garcia-Fernandez E, et al. Usefulness of echocardiographic criteria for transcatheter aortic valve implantation without balloon predilation: a single-center experience. J Am Soc Echocardiogr. 2015;28(4):423–429.
  • Abramowitz Y, Maeno Y, Chakravarty T, et al. Aortic angulation attenuates procedural success following self-expandable but not balloon-expandable TAVR. JACC Cardiovasc Imaging. 2016;9(8):964–972.
  • Barbanti M, Sgroi C, Imme S, et al. Usefulness of contrast injection during balloon aortic valvuloplasty before transcatheter aortic valve replacement: a pilot study. EuroIntervention. 2014;10(2):241–247.
  • Patsalis PC, Al-Rashid F, Neumann T, et al. Preparatory balloon aortic valvuloplasty during transcatheter aortic valve implantation for improved valve sizing. JACC Cardiovasc Interv. 2013;6(9):965–971.
  • Manoharan G, Grube E, Van Mieghem NM, et al. Thirty-day clinical outcomes of the Evolut PRO self-expanding transcatheter aortic valve: the international FORWARD PRO study. EuroIntervention. 2020;16(10):850–857.
  • Forrest JK, Kaple RK, Tang GHL, et al. Three generations of self-expanding transcatheter aortic valves: a report from the STS/ACC TVT Registry. JACC Cardiovasc Interv. 2020;13(2):170–179.
  • Takagi K, Latib A, Al-Lamee R, et al. Predictors of moderate-to-severe paravalvular aortic regurgitation immediately after CoreValve implantation and the impact of postdilatation. Catheter Cardiovasc Interv. 2011;78(3):432–443.
  • Barbanti M, Yang TH, Rodes Cabau J, et al. Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement. Circulation. 2013;128(3):244–253.
  • Nombela-Franco L, Rodes-Cabau J, DeLarochelliere R, et al. Predictive factors, efficacy, and safety of balloon post-dilation after transcatheter aortic valve implantation with a balloon-expandable valve. JACC Cardiovasc Interv. 2012;5(5):499–512.
  • Kim WK, Schafer U, Tchetche D, et al. Incidence and outcome of peri-procedural transcatheter heart valve embolization and migration: the TRAVEL registry (transcatheter heart valve embolization and migration). Eur Heart J. 2019;40(38):3156–3165.
  • Dvir D, Webb JG, Bleiziffer S, et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA. 2014;312(2):162–170.
  • Allen KB, Chhatriwalla AK, Saxon JT, et al. Bioprosthetic valve fracture: Technical insights from a multicenter study. J Thorac Cardiovasc Surg. 2019;158(5):1317–1328 e1311.
  • Brinkmann C, Abdel-Wahab M, Bedogni F, et al. Outcomes of valve-in-valve transcatheter aortic valve implantation with and without bioprosthetic valve fracture. EuroIntervention. 2021;17(10):848–855.
  • Chhatriwalla AK, Allen KB, Saxon JT, et al. Bioprosthetic valve fracture improves the hemodynamic results of valve-in-valve transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2017;10(7).
  • Allen KB, Chhatriwalla AK, Cohen DJ, et al. bioprosthetic valve fracture to facilitate transcatheter valve-in-valve implantation. Ann Thorac Surg. 2017;104(5):1501–1508.
  • Ford TJ, Nguyen K, Brassil J, et al. Balloon aortic valvuloplasty in the transcatheter valve era: single centre indications and early safety data in a high risk population. Heart Lung Circ. 2018;27(5):595–600.
  • Gajanana D, Wheeler D, Hsi D, et al. Percutaneous balloon aortic valvuloplasty and clinical outcomes in severe aortic stenosis: correlation of procedural technique and efficacy. J Interv Cardiol. 2016;29(6):612–618.
  • Dall’Ara G, Marzocchi A, Taglieri N, et al. Randomized comparison of balloon aortic valvuloplasty performed with or without rapid cardiac pacing: the pacing versus no pacing (PNP) study. J Interv Cardiol. 2018;31(1):51–59.
  • Konishi A, Iwasaki M, Omori T, et al. The effect of multiple-inflation balloon aortic valvuloplasty. Heart Vessels. 2020;35(11):1557–1562.
  • Piayda K, Wimmer AC, Sievert H, et al. Contemporary use of balloon aortic valvuloplasty and evaluation of its success in different hemodynamic entities of severe aortic valve stenosis. Catheter Cardiovasc Interv. 2021;97(1):E121–E129.
  • Douglas PS, Hahn RT, Pibarot P, et al. Hemodynamic outcomes of transcatheter aortic valve replacement and medical management in severe, inoperable aortic stenosis: a longitudinal echocardiographic study of cohort B of the PARTNER trial. J Am Soc Echocardiogr. 2015;28(2):210–217 e211–219.
  • Rigatelli G, Dell’Avvocata F, Conte L, et al. Modified balloon aortic valvuloplasty in fragile symptomatic patients unsuitable for both surgical and percutaneous valve replacement. Cardiovasc Revasc Med. 2018;19(4):444–447.
  • Pedersen WR, Goldenberg IF, Pedersen CW, et al. Balloon aortic valvuloplasty in high risk aortic stenosis patients with left ventricular ejection fractions <20%. Catheter Cardiovasc Interv. 2014;84(5):824–831.
  • Spiro J, Venugopal V, Raja Y, et al. Feasibility and efficacy of the 2.5 L and 3.8 L impella percutaneous left ventricular support device during high-risk, percutaneous coronary intervention in patients with severe aortic stenosis. Catheter Cardiovasc Interv. 2015;85(6):981–989.
  • Daniec M, Sorysz D, Dziewierz A, et al. In-hospital and long-term outcomes of percutaneous balloon aortic valvuloplasty with concomitant percutaneous coronary intervention in patients with severe aortic stenosis. J Interv Cardiol. 2018;31(1):60–67.
  • Singh V, Patel NJ, Badheka AO, et al. Comparison of outcomes of balloon aortic valvuloplasty plus percutaneous coronary intervention versus percutaneous aortic balloon valvuloplasty alone during the same hospitalization in the United States. Am J Cardiol. 2015;115(4):480–486.
  • Ben-Dor I, Maluenda G, Looser PM, et al. Outcomes of concomitant percutaneous coronary intervention and balloon aortic valvuloplasty. Catheter Cardiovasc Interv. 2013;82(7):E835–841.
  • Parikh PB, Weber-Fishkin S, George S, et al. Balloon aortic valvuloplasty with same-setting complex percutaneous coronary intervention in the tavr era: a case series. J Invasive Cardiol. 2021;33(6):E479–E482.
  • Scarsini R, Pesarini G, Zivelonghi C, et al. Coronary physiology in patients with severe aortic stenosis: comparison between fractional flow reserve and instantaneous wave-free ratio. Int J Cardiol. 2017;243:40–46.
  • Cubeddu RJ, Jneid H, Don CW, et al. Retrograde versus antegrade percutaneous aortic balloon valvuloplasty: immediate, short- and long-term outcome at 2 years. Catheter Cardiovasc Interv. 2009;74(2):225–231.
  • Dall’Ara G, Tumscitz C, Grotti S, et al. Contemporary balloon aortic valvuloplasty: changing indications and refined technique. Catheter Cardiovasc Interv. 2021;97(7):E1033–E1042.
  • Yamen E, Daniels DV, Van H, et al. Use of a low-profile, compliant balloon for percutaneous aortic valvuloplasty. Catheter Cardiovasc Interv. 2010;75(5):794–798.
  • Williams T, Hildick-Smith DJR. Balloon aortic valvuloplasty: indications, patient eligibility, technique and contemporary outcomes. Heart. 2020;106(14):1102–1110.
  • Ishizu K, Kawaguchi T, Shirai S, et al. Retrograde balloon aortic valvuloplasty with the newly invented Inoue balloon for aortic stenosis accompanied by severe heart failure: a case report. Clin Case Rep. 2021;9(4):2011–2015.
  • Goldenberg E, Pedersen W, Brilakis ES, et al. Improvement in aortic valve area in patients with aortic stenosis through use of a new “hourglass-shaped” valvuloplasty balloon. J Invasive Cardiol. 2017;29(12):411–415.
  • Schneeberger Y, Schaefer A, Schofer N, et al. Transcatheter aortic valve implantation utilizing a non-occlusive balloon for predilatation. Int J Cardiol. 2019;275:65–69.
  • Di Cesare A, Tonet E, Campo G, et al. Snuffbox approach for balloon aortic valvuloplasty: a case series. Catheter Cardiovasc Interv. 2021;97(5):E743–E747.
  • Dall’Ara G, Saia F, Moretti C, et al. Incidence, treatment, and outcome of acute aortic valve regurgitation complicating percutaneous balloon aortic valvuloplasty. Catheter Cardiovasc Interv. 2017;89(4):E145–E152.
  • Ninomiya R, Yoshizawa M, Koeda Y, et al. Safety and feasibility of retrograde INOUE-BALLOON for balloon aortic valvuloplasty without rapid ventricular pacing during transcatheter aortic valve replacement. Cardiovasc Interv Ther. 2021.
  • Witzke C, Don CW, Cubeddu RJ, et al. Impact of rapid ventricular pacing during percutaneous balloon aortic valvuloplasty in patients with critical aortic stenosis: should we be using it? Catheter Cardiovasc Interv. 2010;75(3):444–452.
  • Hilling-Smith R, Cockburn J, Dooley M, et al. Rapid pacing using the 0.035-in. Retrograde left ventricular support wire in 208 cases of transcatheter aortic valve implantation and balloon aortic valvuloplasty. Catheter Cardiovasc Interv. 2017;89(4):783–786.
  • Kleczynski P, Dziewierz A, Socha S, et al. Direct rapid left ventricular wire pacing during balloon aortic valvuloplasty. J Clin Med. 2020;9(4):1017.
  • Badheka AO, Patel NJ, Singh V, et al. Percutaneous aortic balloon valvotomy in the United States: a 13-year perspective. Am J Med. 2014;127(8):744–753 e743.
  • Sgroi C, Gulino S, Attizzani GF, et al. Valve rupture after balloon aortic valvuloplasty successfully managed with emergency transcatheter aortic valve implantation. Int J Cardiol. 2013;168(1):e13–14.
  • Ussia GP, Sarkar K, Tamburino C. Aortic valve perforation during aortic valvuloplasty: identification and strategies for prevention. Catheter Cardiovasc Interv. 2011;77(6):876–880.
  • Loncar S, Perlman G, Planer D, et al. Acute aortic regurgitation and hemodynamic collapse after balloon aortic valvuloplasty. Int J Cardiol. 2014;171(1):88–89.
  • Ali O, Salinger MH, Levisay JP, et al. High pacing rates for management of aortic insufficiency after balloon aortic valvuloplasty or transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2014;83(1):162–168.
  • Saia F, Marrozzini C, Ciuca C, et al. Is balloon aortic valvuloplasty safe in patients with significant aortic valve regurgitation? Catheter Cardiovasc Interv. 2012;79(2):315–321.
  • Li Y, Pang K, Liu Y, et al. Ultrasound-guided percutaneous balloon aortic valvuloplasty for aortic stenosis. J Interv Cardiol. 2020;2020:8086796.
  • Dall’Ara G, Santarelli A, Marzocchi A, et al. Vascular complications after balloon aortic valvuloplasty in recent years: incidence and comparison of two hemostatic devices. Catheter Cardiovasc Interv. 2018;91(6):E49–E55.
  • Ben-Dor I, Looser P, Bernardo N, et al. Comparison of closure strategies after balloon aortic valvuloplasty: suture mediated versus collagen based versus manual. Catheter Cardiovasc Interv. 2011;78(1):119–124.
  • O’Neill B, Singh V, Kini A, et al. The use of vascular closure devices and impact on major bleeding and net adverse clinical events (NACEs) in balloon aortic valvuloplasty: a sub-analysis of the BRAVO study. Catheter Cardiovasc Interv. 2014;83(1):148–153.
  • Sobolev M, Slovut DP, Lee Chang A, et al. Ultrasound-guided catheterization of the femoral artery: a systematic review and meta-analysis of randomized controlled trials. J Invasive Cardiol. 2015;27(7):318–323.
  • Auffret V, Puri R, Urena M, et al. Conduction Disturbances After Transcatheter Aortic Valve Replacement: current Status and Future Perspectives. Circulation. 2017;136(11):1049–1069.
  • Laynez A, Ben-Dor I, Hauville C, et al. Frequency of cardiac conduction disturbances after balloon aortic valvuloplasty. Am J Cardiol. 2011;108(9):1311–1315.
  • Alperi A, Muntane-Carol G, Freitas-Ferraz AB, et al. Overcoming the transcatheter aortic valve replacement Achilles heel: conduction abnormalities-a systematic review. Ann Cardiothorac Surg. 2020;9(6):429–441.
  • Attisano T, Silverio A, Stabile E, et al. Safety and feasibility of balloon aortic valvuloplasty in non-TAVI centers: the “BAV for life” experience. Catheter Cardiovasc Interv. 2019;93(1):E63–E70.
  • Babaliaros V, Devireddy C, Lerakis S, et al. Comparison of transfemoral transcatheter aortic valve replacement performed in the catheterization laboratory (minimalist approach) versus hybrid operating room (standard approach): outcomes and cost analysis. JACC Cardiovasc Interv. 2014;7(8):898–904.
  • Reddy KP, Groeneveld PW, Giri J, et al. Economic considerations in access to transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2022;15(2).
  • Banovic M, Putnik S, Penicka M, et al. Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis: the AVATAR trial. Circulation. 2022;145(9):648–658.
  • Kang DH, Park SJ, Lee SA, et al. Early surgery or conservative care for asymptomatic aortic stenosis. N Engl J Med. 2020;382(2):111–119.
  • Baumbach A, Mylotte D, Hildick-Smith D, et al. Non-implant valve repair for calcific aortic stenosis: the leaflex study. EuroIntervention. 2021;16(16):1366–1369.
  • Messas E, IJ A, Goudot G, et al. Feasibility and performance of noninvasive ultrasound therapy in patients with severe symptomatic aortic valve stenosis: a first-in-human study. Circulation. 2021;143(9):968–970.
  • Sharma A, Bertog S, Mbai M. Transcatheter aortic valve lithotripsy in severely calcified bicuspid aortic stenosis prior to transcatheter aortic valve implantation. Eur Heart J. 2021;42(4):358.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.